In the control group , four patients ( @ % ) developed no-reflow compared to none in the adenosine-treated patient ; P < @ CONCLUSIONS : This study provides the first evidence that high-dose intragraft adenosine infusion compared with placebo protects microvascular function and prevents no-reflow during SVGs intervention .